Logo
Veuillez prendre note que cet événement sera présenté en anglais.
Une transcription en français sera disponible pour la rediffusion.
 If you have previously registered for this event, please login below:
 Email
 LOGIN

Registration is required to attend this event. Please register now.
First Name*
Last Name*
Email*
City*
I am a*
Submit questions you have for the speakers below. These will be answered in the last 20 minutes of the event.
You must have Javascript and Cookies enabled to access this webcast. Click here for Help.
 
Please enable Cookies in your browser before registering for the webcast.
 
*Denotes required.
 
Date: Wednesday November 21, 2018
Time: 02:00 PM EST

Overview

Learn from the CEOs of two of Canada’s leading cannabis firms, hosted by the sub-advisor to Canada’s #1 performing mutual fund on a 1-year basis*, Charles Taerk.

*As at September 30, 2018. Source: Morningstar.ca

Charles Taerk

Sub-Advisor to Ninepoint Alternative Health Fund - President & CEO, Faircourt Asset Management

Charles Taerk is a co-founder of Faircourt Asset Management Inc. and sub-Advisor on the Ninepoint Alternative Health Fund. A sought-after speaker on the emerging cannabis market. Charles was instrumental in bringing Canada's first cannabis-based mutual fund to market. Prior to Faircourt, Charles was VP and Managing Director of Charles Schwab Canada, responsible for Investment Banking, Syndication, and Institutional Research.

Peter Aceto

CEO of CannTrust Holdings Inc.

Peter Aceto is the Chief Executive Officer of CannTrust Holdings Inc. since October 1, 2018. He served as the Chief Executive Officer and President of Tangerine Bank (also known as ING Bank of Canada) from 2008 to March 01, 2017. Mr. Aceto was the Founding Member of senior leadership team at ING Bank. Mr. Aceto served as an Executive Vice President, Head of Credit, Chief Lending Officer, Chief Risk Officer, Chief of Staff and Chief Sales and Marketing Officer of ING Bank from March 2002 to April 2008. He serves as a Director of ING Direct Asset Management Limited and Tangerine Bank.

Greg Engel

CEO, Director of OrganiGram Holdings Inc.

Greg Engel has been Chief Executive Officer of OrganiGram Holdings Inc. since March 13, 2017. Mr. Engel has served in a number of senior-level and executive positions in related industries over the past 25 years in Canada, US and Internationally. He served as Chief Executive Officer for Tilray Canada Inc. since January 2015 until January 2016, an early medical marijuana leader and the first Canadian company to export medical cannabis products to Europe.

Mike Gorenstein

CEO, Cronos Group Inc.

Michael Gorenstein holds the position of Chairman, President & Chief Executive Officer for Cronos Group, Inc. He previously held the position of Associate at Sullivan & Cromwell LLP, Partner at Alphabet Ventures LLC and General Counsel & Vice President at Saiers Capital LLC.